Molecular Subtypes of Pancreatic Cancer: A Proteomics Approach.

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)

Through molecular subtyping, therapeutic vulnerabilities can be exploited for developing personalized medicine. The real utility of molecular subtyping lies in the clinical translation for disease characterization. Proteomic methods with defined marker sets hold great promise for improving therapy outcomes by improving the speed of predictions for devising treatment strategies.See related article by Son et al., p. 3370.

Keyphrases

single molecule
mass spectrometry
type diabetes
stem cells
bone marrow
machine learning
mesenchymal stem cells
insulin resistance
weight loss
glycemic control
artificial intelligence